Ole Henriksen: How health technology assessments transformed clinical development
Send us Fan Mail
This week we speak to Ole Henriksen, Associated Partner of Nordic Healthcare Group and pharmaceutical market access expert. We speak about how health technology assessments (HTA) has impacted how we conduct clinical trials.
Health Technology Assessment (HTA) emerged first as a research area in decision aids. Later, during the 1990s, as a formal requirement for reimbursement.
Due to it being a requirement in many markets, it is often called “the 4th hurdle”. It should be understood in addition to regulatory requirements on efficacy, safety and quality, HTA poses a 4th…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.